Saturday, July 11, 2026

pharma · Multiple System Atrophy · Asthma

Second Affiliated Hospital

Second Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Multiple System Atrophy, Asthma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 paten

Hangzhou, CN HQ
1869 Founded
16 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hangzhou, CN
Founded
1869
Employees
16
Programs
2
Drugs
4
Patents
0
Clinical program

3-N-butylphthalide

Phase 3 · small molecule · Multiple System Atrophy

3-N-butylphthalide for Multiple System Atrophy is a Phase 3 program (small_molecule) at Second Affiliated Hospital, School of Medicine, Zhejiang University with 1 ClinicalTrials.gov record(s).

Internal code 2025-1012

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase
Phase 3
Modality
small_molecule
Indication
Multiple System Atrophy
Status
active
Trials
1